Founder mutations and the high prevalence of myotonia congenita in northern Finland

Neurology

Volumn 53, Issue 2, 1999, Pages 297-302

  Papponen, H ^c   Toppinen, T ^c   Baumann, P ^c   Myllyla V ^c   Leisti, J ^c   Kuivaniemi, H ^a   Tromp, G ^a   Myllylä, Raili ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FINLAND; FOUNDER EFFECT; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THOMSEN DISEASE;

EID: 0033595186     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.2.297     Document Type: Article

References (27)

1. Becker PE. Myotonia congenita and syndromes associated with myotonia. In: Becker PE, Lenz W, Vogel F, Wendt GG, eds. Topics in human genetics. Vol 3. Stuttgart: Georg Thieme, 1977: 1-179.
2. Thomsen J. Tonische Krämpfe in willkürlich beweglichen Muskeln in Folge ärbter psychischer Disposition (Ataxia muscularis). Arch Psychiatr Nervenkr 1876;6:702-718.
3. Rudel R, Lehmann-Horn F. Membrane changes in cells from myotonia patients. Physiol Rev 1985;65:310-356.
4. Rudel R, Ricker K, Lehmann-Horn F. Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker). Muscle Nerve 1988;11:202-211.
5. Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797-800.
6. Hoffman EP, Lehmann-Horn F, Rüdel R. Overexcited or inactive: ion channels in muscle disease. Cell 1995;80:681-686.
7. Koty PP, Pegoraro E, Hobson G, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology 1996;47:963-968.
8. Jentsch TJ, Günther W. Chloride channels: an emerging molecular picture. BioEssays 1997;19:117-126.
9. Steinmeyer K, Ortland C, Jentsch TJ. Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel. Nature 1991;354:301-304.
10. Lorenz C, Meyer-Kleine C, Steinmeyer K, Koch MC, Jentsch TJ. Genomic organization of the human muscle chloride channel ClC-1 and analysis of novel mutations leading to Becker-type myotonia. Hum Mol Genet 1994;3:941-946.
11. Pinessi L, Bergamini L, Cantello R, Di Tizio C. Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979). Ital J Neurol Sci 1982;3:207-210.
12. Baumann P, Myllylä W, Leisti J. Myotonia congenita in northern Finland: an epidemiological study. J Med Genet 1998;35:293-296.
13. George AL Jr, Sloan-Brown K, Fenichel GM, Mitchell GA, Spiegel R, Pascuzzi RM. Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet 1994;3:2071-2072.
14. Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch TJ, Koch MC. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet 1995;57:1325-1334.
15. Zhang J, George AL Jr, Griggs RC, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology 1996;47:993-998.
16. Sloan-Brown K, George AL Jr. Inheritance of three distinct muscle chloride channel gene (CLCN1) mutations in a single recessive myotonia congenita family. Neurology 1997;48:542-543.
17. Esteban J, Neumeyer AM, McKenna-Yasek D, Brown RH. Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker's generalized myotonia. Neurogenetics 1998;1:185-188.
18. Plassart-Schiess E, Gervais BS, Eymard B, et al. Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology 1998;50:1176-1179.
19. Norio R, Nevanlinna HR, Perheentupa J. Hereditary diseases in Finland: rare flora in rare soul. Ann Clin Res 1973;5:109-141.
20. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 1993;30: 857-865.
21. Peltonen L, Pekkarinen P, Aaltonen J. Messages from an isolate: lessons from the Finnish gene pool. Biol Chem Hoppe Seyler 1995;376:697-704.
22. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. New York: John Wiley & Sons, 1989.
23. Lehmann-Horn F, Mailänder V, Heine R, George AL. Myotonia levior is a chloride channel disorder. Hum Mol Genet 1995;4:1397-1402.
24. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
25. Schmidt-Rose T, Jentsch TJ. Transmembrane topology of a CLC chloride channel. Proc Natl Acad Sci USA 1997;94:7633-7638.
26. Wagner S, Deymzeer F, Kürz LL, et al. The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology. Muscle Nerve 1998;21:1122-1128.
27. Nevanlinna R. The Finnish population structure: a genetic and genealogical study. Hereditas 1972;71:195-236.